Viewing StudyNCT06360419

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 8:24 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06360419
Status: RECRUITING
Last Update Posted: 2024-04-11
First Post: 2024-04-08
Brief Title: Progressing TAAR-1 Dopamine and Norepinephrine in Depression Using Solriamfetol
Sponsor: Axsome Therapeutics Inc
Organization: Axsome Therapeutics Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Major Depressive Disorder
Keywords:
Name View
Solriamfetol View
Sunosi View
MDD View
Major Depressive Disorder View
Axsome View
Non-stimulant therapy View
Dopamine norepinephrine reuptake inhibitor View
Trace amine-associated receptor 1 TAAR1 agonist View